COM:BLUEPRINTMEDICINES
Blueprint Medicines
- Stock
Last Close
96.62
22/11 21:00
Market Cap
5.90B
Beta: -
Volume Today
663.53K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -27.03M - | -27.03M 0% | -217.01M - | -212.72M 1.98% | 15.20M 107.15% | 25.76M 69.47% | 25.46M 1.15% | |||||
average payables | 1.11M - | 1.63M 46.72% | 2.33M 42.73% | 2.98M 27.63% | 3.52M 18.25% | 4.05M 14.90% | 4.58M 13.25% | 6.35M 38.63% | 5.53M 12.92% | 3.72M 32.75% | ||
average receivables | 1.71M - | 3.50M 104.77% | 1.79M 48.83% | 11.71M - | 24.36M 108.10% | 31.17M 27.95% | 36.98M 18.65% | 40.06M 8.31% | ||||
book value per share | -0.11 - | 2.71 2,468.25% | 7.90 191.55% | 7.75 1.83% | 16.51 113.02% | 9.55 42.15% | 9.71 1.64% | 26.96 177.66% | 16.59 38.46% | 8.63 47.98% | 2.16 75.01% | |
capex per share | -0.02 - | -0.05 172.37% | -0.27 400.46% | -0.09 68.02% | -0.41 379.35% | -0.29 29.59% | -0.29 1.38% | -0.06 80.23% | -4.46 7,606.72% | -0.15 96.65% | -0.27 77.36% | |
capex to depreciation | -0.51 - | -1.13 119.39% | -5.15 357.69% | -1.49 71.11% | -9.83 560.63% | -2.99 69.63% | -2.66 10.75% | -0.48 81.92% | -40.32 8,271.85% | -0.76 98.12% | -1.38 81.17% | |
capex to operating cash flow | 0.01 - | 0.02 46.38% | 0.15 679.58% | 0.10 37.70% | 0.13 34.76% | 0.07 44.03% | 0.05 30.42% | -0.01 116.19% | 0.87 10,817.05% | 0.02 97.97% | 0.04 107.06% | |
capex to revenue | -0.43 - | -0.08 80.21% | -0.72 754.14% | -0.28 60.67% | -0.21 26.01% | -0.00 98.11% | -1.45 36,350.35% | -0.04 96.99% | -0.06 47.34% | |||
cash per share | 0.15 - | 3.61 2,277.45% | 8.92 147.10% | 15.65 75.43% | 25.04 59.99% | 11.26 55.03% | 10.11 10.23% | 15.99 58.13% | 8.15 49.00% | 15.84 94.33% | 11.73 25.94% | |
days of inventory on hand | 7.37K - | 444.03 93.97% | 608.51 37.04% | 316.68 47.96% | ||||||||
days payables outstanding | 3.75K - | 169.60 95.48% | 55.92 67.03% | 70.28 25.68% | ||||||||
days sales outstanding | 109.31 - | 47.01 56.99% | 128.48 - | 11.64 90.94% | 75.06 544.89% | 66.08 11.96% | 63.20 4.36% | |||||
debt to assets | 0.69 - | 0.18 73.84% | 0.04 75.95% | 0.02 47.24% | 0.03 18.93% | 0.03 10.62% | 0.14 348.41% | 0.05 61.54% | 0.09 70.62% | 0.18 101.88% | 0.66 267.40% | |
debt to equity | -1.91 - | 0.26 113.34% | 0.05 78.79% | 0.03 43.64% | 0.03 2.79% | 0.04 24.31% | 0.21 430.15% | 0.06 70.50% | 0.11 88.29% | 0.47 310.46% | 5.30 1,025.32% | |
dividend yield | 0.00 - | 0.00 123.18% | 0.00 53.69% | |||||||||
earnings yield | -0.08 - | -0.16 92.64% | -0.11 32.68% | -0.09 14.43% | -0.05 44.72% | -0.10 92.54% | -0.09 14.27% | 0.05 159.82% | -0.10 300.23% | -0.21 107.64% | -0.09 57.46% | |
enterprise value | 247.75M - | 208.68M 15.77% | 321.58M 54.10% | 506.30M 57.44% | 2.19B 333.13% | 2.31B 5.40% | 3.81B 64.99% | 5.52B 44.77% | 6.17B 11.74% | 2.74B 55.66% | 6.29B 129.88% | |
enterprise value over ebitda | -12.22 - | -5.32 56.45% | -6.18 16.04% | -7.03 13.83% | -14.83 110.93% | -9.77 34.10% | -10.55 8.02% | 17.88 269.45% | -9.61 153.73% | -5.09 47.04% | -13.25 160.35% | |
ev to operating cash flow | -13.02 - | -5.89 54.73% | -10.15 72.22% | -20.65 103.45% | -18.30 11.42% | -13.21 27.81% | -13.72 3.86% | 14.26 203.99% | -20.66 244.81% | -5.45 73.63% | -14.40 164.31% | |
ev to sales | 28.21 - | 18.23 35.37% | 102.35 461.41% | 51.92 49.27% | 57.34 10.44% | 6.96 87.87% | 34.26 392.53% | 13.41 60.86% | 25.22 88.08% | |||
free cash flow per share | -1.47 - | -2.76 87.22% | -2.00 27.35% | -0.98 51.25% | -3.58 266.54% | -4.28 19.44% | -6.11 42.71% | 7.04 215.29% | -9.57 235.92% | -8.57 10.42% | -7.48 12.74% | |
free cash flow yield | -0.08 - | -0.15 87.22% | -0.08 47.95% | -0.03 54.22% | -0.05 36.34% | -0.08 67.08% | -0.08 3.97% | 0.06 182.35% | -0.09 242.32% | -0.20 119.02% | -0.08 58.56% | |
graham net net | -0.28 - | 2.50 998.57% | 7.15 185.60% | 12.23 71.11% | 22.61 84.89% | 8.50 62.41% | 0.85 89.97% | 11.86 1,291.54% | 4.00 66.24% | 2.55 36.22% | -2.72 206.69% | |
graham number | 2.03 - | 13.70 575.44% | 22.67 65.53% | 21.44 5.42% | 38.16 77.93% | 34.05 10.76% | 38.75 13.79% | 59.09 52.49% | 64.09 8.48% | 42.60 33.53% | 20.16 52.69% | |
income quality | 0.91 - | 0.88 3.41% | 0.60 31.69% | 0.34 43.67% | 0.81 139.33% | 0.74 8.61% | 0.80 8.12% | 1.23 54.21% | 0.46 62.40% | 0.90 94.29% | 0.86 4.36% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -152.17 - | -87.71 42.36% | -74.20 15.40% | -154.75 108.55% | -684.38 342.25% | -3.38K 394.46% | -26.70 99.21% | -32.76 - | -9.42 71.23% | |||
interest debt per share | 0.23 - | 0.73 216.39% | 0.47 35.87% | 0.25 45.55% | 0.52 106.54% | 0.37 28.57% | 2.29 513.24% | 1.64 28.35% | 1.90 15.87% | 4.35 128.29% | 12.29 182.67% | |
inventory turnover | 0.05 - | 0.82 1,559.71% | 0.60 27.03% | 1.15 92.15% | ||||||||
invested capital | -1.91 - | 0.26 113.34% | 0.05 78.79% | 0.03 43.64% | 0.03 2.79% | 0.04 24.31% | 0.21 430.15% | 0.06 70.50% | 0.11 88.29% | 0.47 310.46% | 5.30 1,025.32% | |
market cap | 246.88M - | 246.88M 0% | 480.34M 94.57% | 771.15M 60.54% | 2.85B 269.57% | 2.36B 17.02% | 3.83B 62.02% | 6.12B 59.62% | 6.27B 2.48% | 2.61B 58.31% | 5.59B 113.78% | |
net current asset value | -3.18M - | 33.78M 1,161.20% | 135.50M 301.14% | 150.71M 11.23% | 593.74M 293.97% | 378.67M 36.22% | 273.45M 27.79% | 679.45M 148.47% | 272.54M 59.89% | 211.43M 22.42% | -110.25M 152.14% | |
net debt to ebitda | -0.04 - | 0.97 2,354.54% | 3.05 212.96% | 3.68 20.61% | 4.44 20.81% | 0.23 94.91% | 0.05 77.96% | -1.93 3,971.56% | 0.15 107.96% | -0.23 248.77% | -1.48 548.51% | |
net income per share | -1.60 - | -3.08 92.64% | -2.89 6.02% | -2.64 8.87% | -3.92 48.63% | -5.39 37.64% | -6.87 27.40% | 5.76 183.75% | -11.01 291.23% | -9.35 15.07% | -8.37 10.44% | |
operating cash flow per share | -1.45 - | -2.71 86.07% | -1.74 35.80% | -0.89 48.67% | -3.17 255.71% | -3.99 25.79% | -5.81 45.70% | 7.10 222.10% | -5.10 171.91% | -8.42 65.01% | -7.21 14.34% | |
payables turnover | 0.10 - | 2.15 2,112.93% | 6.53 203.29% | 5.19 20.44% | ||||||||
receivables turnover | 3.34 - | 7.76 132.51% | 2.84 - | 31.36 1,003.92% | 4.86 84.49% | 5.52 13.59% | 5.78 4.56% | |||||
research and ddevelopement to revenue | 4.26 - | 2.92 31.46% | 6.75 131.16% | 5.47 18.97% | 4.98 8.93% | 0.41 91.74% | 3.34 710.49% | 2.34 29.89% | 1.67 28.70% | |||
return on tangible assets | -5.06 - | -0.81 84.04% | -0.29 63.44% | -0.26 13.09% | -0.21 19.27% | -0.44 111.71% | -0.46 6.01% | 0.18 139.33% | -0.51 381.59% | -0.41 19.70% | -0.48 16.99% | |
revenue per share | 0.63 - | 1.01 61.59% | 0.57 43.88% | 1.01 79.02% | 1.39 37.02% | 14.55 946.65% | 3.08 78.86% | 3.42 11.17% | 4.12 20.37% | |||
roe | 13.98 - | -1.14 108.13% | -0.37 67.77% | -0.34 7.17% | -0.24 30.23% | -0.56 137.91% | -0.71 25.34% | 0.21 130.16% | -0.66 410.76% | -1.08 63.26% | -3.88 258.34% | |
roic | -15.63 - | -0.90 94.23% | -0.33 63.68% | -0.32 1.33% | -0.23 28.09% | -0.57 146.79% | -0.53 7.88% | 0.18 134.57% | -0.55 398.96% | -0.64 18.05% | -0.54 16.43% | |
sales general and administrative to revenue | 1.27 - | 0.69 45.43% | 1.31 88.76% | 1.08 17.58% | 1.45 34.62% | |||||||
shareholders equity per share | -0.11 - | 2.71 2,468.25% | 7.90 191.55% | 7.75 1.83% | 16.51 113.02% | 9.55 42.15% | 9.71 1.64% | 26.96 177.66% | 16.59 38.46% | 8.63 47.98% | 2.16 75.01% | |
stock based compensation to revenue | 0.45 - | 0.22 51.34% | 0.58 164.37% | 0.69 17.34% | 0.82 19.81% | 0.10 88.42% | 0.51 434.75% | 0.49 4.67% | 0.37 23.39% | |||
tangible asset value | -1.50M - | 35.43M 2,468.25% | 143.98M 306.39% | 213.08M 47.99% | 623.97M 192.84% | 419.01M 32.85% | 464.36M 10.82% | 1.47B 216.58% | 970.74M 33.97% | 514.68M 46.98% | 130.61M 74.62% | |
tangible book value per share | -0.11 - | 2.71 2,468.25% | 7.90 191.55% | 7.75 1.83% | 16.51 113.02% | 9.55 42.15% | 9.71 1.64% | 26.96 177.66% | 16.59 38.46% | 8.63 47.98% | 2.16 75.01% | |
working capital | -705K - | 41.51M 5,987.94% | 151.78M 265.64% | 191.91M 26.44% | 642.62M 234.85% | 439.46M 31.61% | 410.30M 6.64% | 796.96M 94.24% | 404.26M 49.27% | 863.42M 113.58% | 593.47M 31.26% |
All numbers in (except ratios and percentages)